Company Announces Three Reporting Segments as of Q1 FY15
SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov. 20, 2014--
Agilent Technologies Inc. (NYSE:A) today announced it has named two new
business presidents and realigned its businesses to better serve
customers.
Patrick Kaltenbach has been named senior vice president, Agilent, and
president of the Life Sciences and Applied Markets Group (LSAG) business
unit, which combines the former Chemical Analysis Group and Life
Sciences business. The combination will result in most of Agilent’s
instrumentation and software being in one organization to better serve
analytical laboratories with similar needs.
Jacob Thaysen has been appointed senior vice president, Agilent, and
president of the Diagnostics and Genomics Group (DGG). This new business
unit combines the Diagnostics and Genomics businesses and will serve the
needs of clinical laboratories.
Both appointments are effective immediately. Fred Strohmeier, who has
been president of the Life Sciences and Diagnostics Group (LDG), has
announced his retirement, planned for the second quarter of FY15. He
will serve as an advisor to the company until that time.
“I would like to thank Fred for his more than 35 years of contributions
to the company,” said Mike McMullen, Agilent president, chief operating
officer and CEO-elect. “Building on his years of experience in life
sciences, Fred most recently provided superb leadership of Agilent’s
entry into diagnostics. I wish him the best in his retirement.”
“The organization we’re announcing today is about serving our customers
with ease, efficiency and a single voice,” McMullen added. “By combining
our businesses around market needs, rather than technologies, we provide
our customers with an easier, more direct way to get the products,
software and services they need.
“I am excited about the addition of Patrick and Jacob as business
presidents. They are both proven leaders with deep knowledge and
exceptional customer insights across the range of our businesses. The
formation of our high-caliber executive team marks another step toward
positioning Agilent to deliver on its outstanding growth opportunities.”
About Patrick Kaltenbach
As group president for LSAG, Kaltenbach is responsible for leading
Agilent’s life sciences and applied chemical markets business.
Kaltenbach was most recently Agilent vice president and general manager
of the Life Sciences Products and Solutions organization, where he had
responsibility for the strategic direction and development of all
Agilent life science products.
Kaltenbach joined Agilent’s predecessor, Hewlett-Packard Co., in 1991 as
an R&D engineer in the Capillary Electrophoresis business. He has held
various management positions within R&D and senior management roles over
the years. Kaltenbach holds a degree in precision engineering from the
Karlsruhe University of Applied Science in Germany.
About Jacob Thaysen
As group president of DGG, Thaysen is now responsible for the strategic
direction and day-to-day management of Agilent’s diagnostics and
genomics business.
Thaysen was most recently vice president and general manager of
Agilent’s Diagnostics and Genomics business within LDG. He was
responsible for its overall operation, including strategic direction,
project management, sales, marketing and R&D.
Thaysen joined Agilent in 2012 as part of the Dako acquisition. He was
corporate vice president of R&D at Dako, and prior to that a management
consultant at Copenhagen Consulting Co. (now Quartz+Co.). Previously, he
was a founding partner and chief technology officer of Cantion, a
research and defense application development company.
He holds a Ph.D. in physics from the Technical University of Denmark.
Both Kaltenbach and Thaysen are based at Agilent’s corporate offices in
Santa Clara, California.
New Financial Reporting Segments
Starting in Q1 FY15, Agilent’s reporting segments will be Life Sciences
and Applied Markets (LSAG), Diagnostics and Genomics (DGG), and Agilent
CrossLab Group (ACG). ACG, announced
in September and headed by Mark Doak, includes services and
consumables.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences,
diagnostics and applied chemical markets, is the premier laboratory
partner for a better world. Agilent works with customers in more than
100 countries, providing instruments, software, services and consumables
for the entire laboratory workflow. Agilent generated revenues of $4.0
billion in fiscal 2014. The company employs about 12,000 people
worldwide. Information about Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available on the Agilent news site at www.agilent.com/go/news.
Source: Agilent Technologies Inc.
Agilent Technologies Inc.
EDITORIAL CONTACT:
Michele Drake, +1
408-345-8396
michele_drake@agilent.com
INVESTOR
CONTACT:
Alicia Rodriguez, +1 408-345-8948
alicia_rodriguez@agilent.com